The cost-effectiveness of varicella screening and vaccination in US Army recruits

被引:8
|
作者
Howell, MR [1 ]
Lee, T [1 ]
Gaydos, CA [1 ]
Nang, RN [1 ]
机构
[1] Johns Hopkins Univ, Div Infect Dis, Baltimore, MD 21205 USA
关键词
D O I
10.1093/milmed/165.4.309
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Varicella outbreaks in the U.S. Army disrupt training, reduce readiness, and represent substantial costs. Vaccination of susceptible individuals may be cost-effective. We conducted a cost-effectiveness analysis comparing screening of all incoming recruits and vaccination of susceptible individuals at either initial entry training (IET) or medical entrance processing station (MEPS), universal vaccination at IET, and no intervention. Primary health outcomes included the number of varicella cases prevented during the 8-week initial training period. The varicella hospitalization rate was 21.6 per 10,000 per year. In 100,000 recruits, 36 cases of varicella are expected at a cost of $181,000 in the absence of an intervention. Screening at IET would prevent 4 cases but would cost an additional $3,255,000 more than no intervention. Screening at MEPS would prevent 3 cases and save $521,000 per case prevented during the IET but would cost $2,734,000 more than no intervention. Universal vaccination would prevent 2 cases but would cost $15,858,000 more than MEPS screening and $18,592,000 more than no intervention. These results are robust. Cost per case of varicella prevented ranged from $390,000 to $7.9 million. Scarce prevention resources could be more cost-effectively allocated to other prevention programs.
引用
收藏
页码:309 / 315
页数:7
相关论文
共 50 条
  • [21] Modeling Cost-Effectiveness of Universal Varicella Vaccination With Different Varicella Vaccines in the United Kingdom
    Pawaskar, Manjiri
    Burgess, Colleen
    Pillsbury, Matthew
    Kanibir, M. Nabi
    Platt, Heather L.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (05) : 935 - 936
  • [22] COST-EFFECTIVENESS OF MASS VACCINATION FOR VARICELLA IN FRANCE WITH MMRV VERSUS MMR
    Littlewood, K.
    Vissers, D.
    Ouwens, M.
    Jansen, J. P.
    Postma, M. J.
    VALUE IN HEALTH, 2008, 11 (06) : A433 - A433
  • [23] COST-EFFECTIVENESS OF MASS VARICELLA VACCINATION IN FRANCE: ECONOMIC CONSEQUENCES OF AN INTENSIVE VACCINATION PROGRAM
    Littlewood, K. J.
    Scuboin, L.
    Ouwens, M.
    VALUE IN HEALTH, 2009, 12 (07) : A424 - A424
  • [24] Epidemiological Impact and Cost-Effectiveness of Varicella Vaccination Strategies in the United Kingdom
    Akpo, Esse Ifebi Herve
    Cristeau, Olivier
    Hunjan, Manjit
    Casabona, Giacomo
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (11) : E3617 - E3626
  • [25] Cost-effectiveness analysis of universal childhood vaccination against varicella in Brazil
    Valentim, J.
    Sartori, A. M. C.
    de Soarez, P. C.
    Amaku, M.
    Azevedo, R. S.
    Novaes, H. M. D.
    VACCINE, 2008, 26 (49) : 6281 - 6291
  • [26] Cost-effectiveness of human papillomavirus vaccination and screening in Spain
    Diaz, Mireia
    de Sanjose, Silvia
    Ortendahl, Jesse
    O'Shea, Meredith
    Goldie, Sue J.
    Bosch, F. Xavier
    Kim, Jane J.
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (16) : 2973 - 2985
  • [27] The Cost-Effectiveness of Universal Varicella Vaccination in Italy: A Model-Based Assessment of Vaccination Strategies
    Azzari, C.
    Baldo, V
    Giuffrida, S.
    Gani, R.
    O'Brien, E.
    Alimenti, C.
    Daniels, V. J.
    Wolfson, L. J.
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2020, 12 : 273 - 283
  • [28] The Cost-effectiveness of Varicella Zoster Virus Vaccination Considering Late Onset Asthma
    Ditkowsky, Jared
    Kohlhoff, Stephan
    Smith-Norowitz, Tamar A.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2016, 35 (09) : E275 - E284
  • [29] COST-EFFECTIVENESS OF A ROUTINE VARICELLA VACCINATION PROGRAM FOR UNITED-STATES CHILDREN
    LIEU, TA
    COCHI, SL
    BLACK, SB
    HALLORAN, ME
    SHINEFIELD, HR
    HOLMES, SJ
    WHARTON, M
    WASHINGTON, AE
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (05): : 375 - 381
  • [30] Health Impact and Cost-effectiveness Assessment for the Introduction of Universal Varicella Vaccination in Switzerland
    Heininger, Ulrich
    Pillsbury, Matthew
    Samant, Salome
    Lienert, Florian
    Guggisberg, Patrik
    Gani, Ray
    O'Brien, Elliott
    Pawaskar, Manjiri
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2021, 40 (06) : E217 - E221